“Interesting Publications”
Books and publications I like and would like to share
This article was posted on ConnecticutLyme@yahoogroups.com. This is very important information so I wanted to send it along to you:
“I recently came back from Corfu, Greece where I was awestruck with its
natural, lush terrain and warm- hearted people. A definite must for anyone
wanting island sun, blue skies and delightful Mediterranean cuisine. I
attended the 18th American Biologics Symposium. One of the best lectures
given was on the most recent Lyme disease research by Professor Garth
Nicolson. Here is what I learned from that presentation:
Lyme disease is a tick-borne illness, caused by the Borrelia burgdoferi
spirochete. This infection results in flu-like symptoms, headache and joint
and muscle pain. If the disease is left untreated and infection spreads,
serious health complications can result. According to Professor Garth
Nicolson and the Institute of Molecular Medicine, these chronic conditions,
like fatigue, arthritis, neurological and heart problems are often mistaken
for other health issues. This can make treatment difficult if a late-stage
Lyme disease patient is misdiagnosed with Chronic Fatigue Syndrome or
Rheumatoid Arthritis. Several laboratory tests need to be conducted to
assure a proper diagnosis.
New research from The Institute of Molecular Medicine has shown that Lyme
disease is often accompanied by other infections. The various strains of
the Babesia protozoan, like Babesia microti, Babesia divergens and Babesia
bova, can worsen the symptoms of Lyme disease in humans during the early
stages. Some of these symptoms include weakness, high fever,
gastrointestinal and respiratory problems, and anemia.
Mycoplasmal infections are very common with Lyme disease. Research
indicates that 60 to 70% of individuals with Lyme disease also carry a form
of the Mycoplasma co-infection. It is difficult to identify Mycoplasmal
infections with lab tests. Mycoplasmas require very sensitive tests because
they are not detected freely in the blood, but in various tissues instead.
The symptoms of a Mycoplasmal infection are similar to the Borrelia
burgdoferi infection.
Various strains of Ehrlichia are known to cause a co-infection, resulting in
fever, headache, weakness and pain in the muscles and a low white blood cell
count, among other symptoms.
It is best to treat Lyme disease and the co-infections in its early stages
before the disease progresses. Those patients with Lyme disease and any
co-infections can undergo antibiotic treatment. Dietary changes can help
keep the immune system strong and fight off infection. Diets should include
whole grains, yogurt, wheat germ, cruciferous vegetables, and fish. Patients
should avoid junk foods, refined sugars, alcohol and caffeine. Patients need
to drink plenty of water and juices. It is also important to take vitamin
and mineral supplements. Levels of vitamin C, E, CoQ-10 and B-complex are
often poorer in patients with chronic disease due to absorption problems.
Zinc, magnesium, chromium and selenium stores are often depleted and can be
restored with supplements.
Overuse of antibiotics destroys the “good” bacteria found in the intestines.
This allows room for dangerous bacteria to harvest itself in the intestines.
It is recommended that Lyme disease patients undergoing antibiotic therapy
to add Probiotics to their diet. Lactobacillus acidophilus, Lactobacillus
bifidus, Lactobacillus bulgaricus and several other strains can be taken in
a capsule or powder form. These healthy strains of bacteria replace the
bacteria destroyed by antibiotics and improve gut health. Herbal remedies
also help to improve the immune system. Professor Nicolson found that
ginseng root, herbal teas, bioactive whey protein and olive leaf extract can
help the immune system from relapsing.
Another herbal remedy for Lyme disease is Uncaria tomentosa, also known as
“Cat’s Claw”. Cat’s Claw is found in the product, SamentoR. Cat’s Claw
contains pentacyclic oxindale alkaloids (POA’s), which helps the immune
system fight infection.
This current research conducted by Professor Garth Nicolson
and the Institute of Molecular Medicine shows promising ideas in Lyme
disease. We hope that this research brings about more advancement in the
field to help those with this disease.
References:
1. Nicolson, Garth, Ph.D.”Diagnosis and therapy of chronic systemic
co-infections in Lyme disease and other tick-borne infectious diseases.”
“http://www.immed.org/reports/infectious_disease_illness/LYMETreat-01.9.25.h
tml.”
_____
For more information visit

No Comments »
http://www.washingtonpost.com/wp-dyn/content/article/2010/05/20/AR2010052003038.html
NIH proposes new funding rules to prevent conflicts of interest
By Rob Stein
Friday, May 21, 2010; A16
The National Institutes of Health proposed new guidelines Thursday to prevent financial conflicts of interest among thousands of researchers who receive federal funding, a move long sought by watchdogs of scientific research concerned about the influence of the drug industry and others.
The move, which will affect more than 40,000 researchers, comes amid rising concern about the influence of the pharmaceutical industry and other private-sector interests on scientific research. In a series of high-profile cases, federally funded researchers have received upward of millions of dollars from companies with a financial interest in the outcome of their work.
Among other changes, the new guidelines will reduce from $10,000 to $5,000 the minimum payment that researchers will be required to report and mandate that universities, colleges, research institutes, businesses and other entities that employ researchers who receive NIH funding monitor compliance with the new reporting requirement. Funding information would have to be posted on a publicly accessible Web site. Violators could lose their funding.
“Partnerships between NIH-funded researchers and industry are essential. They have been, and they will be,” NIH Director Francis S. Collins said in announcing the guidelines, which will be subject to 60 days of public comment and possible revision before becoming final. “At the same time, we need to be clear that in order to preserve the public trust in the objectivity of biomedical and behavioral research, all research has to be conducted without bias and with the highest scientific and ethical standards.”
Collins stressed that, in most cases, the integrity of scientific research has not been compromised by outside funding. But even the appearance of a conflict can undermine public trust, he said.
“The public trust in what we do is just essential, and we cannot afford to take any chances with the integrity of the research process,” Collins said.
Universities and professional organizations have been tightening their policies concerning outside funding in recent years to prevent conflicts of interests. The National Academy of Sciences’ Institute of Medicine released a scathing report last year urging doctors to stop accepting money, gifts and free drug samples from drug and medical device companies.
Sen. Charles E. Grassley (R-Iowa), who has been investigating conflicts of interest in federally funded research, welcomed the proposed changes, which he said he planned to review.
“Disclosure of financial relationships and the resulting accountability have been sorely lacking in federally sponsored research,” Grassley said in a statement. “Letting the sun shine in and making information public is basic to building people’s confidence in medicine. And with the taxpayer funding that’s involved, people have a right to know. Public trust and public dollars are at stake.”
Several groups that had been advocating for tougher rules praised the proposal.
“The leaders of the NIH are finally considering seriously an idea they have rejected for years: public disclosure of grantees’ financial arrangements that may create conflicts of interest,” said Ned Feder of the Project on Government Oversight.
Allan Coukell, director of the Pew Prescription Project, a consumer advocacy group, said the rules were a step in the right direction, though there were some shortcomings. The rules should require researchers to report any financial interest, even those less than $5,000, he said. The rules also do not require those receiving more than $250,000 to specify the amount any further.
“From the public’s point of view of trying to assess someone’s financial stake, you’ll have no way of knowing whether they have a $250,000 interest or a $1 million interest,” Coukell said.
A spokesman for PhRMA, which represents the pharmaceutical industry, said the group was reviewing the proposed rules.
No Comments »
Well, I find it very interesting that we may be on our way to understanding depression from a different perspective – especially for those who have been on antidepressants and have not found lasting effective treatment. This new knowledge has led to a natural vitamin treatment without side effects!
GENERAL INFORMATION ABOUT THE GENETIC TEST
The genetic test – which can be done from a simple blood draw- is called the MTHFR test. The official name of this gene is “5,10-methylenetetrahydrofolate reductase” (NADPH). MTHFR is the gene’s official shorthand symbol – and now you know why! Just for an interesting clarification, the gene is located on the short (p) arm of chromosome 1 at position 36.3.
The normal function of this gene provides instructions for making an enzyme called methylenetetrahydrofolate reductase. This hormone plays a key role in processing amino acids, the building blocks of proteins. If a mutation occurs in the MTHFR gene, folate/B vitamins may not be broken down in such a way that the body can utilize them.
(Let it be known that this research and information is very difficult to understand and translate; in fact, it is nearly indecipherable to this lay person! I have struggled with it and the following is hard won information which I hope will help you to understand this complex and emerging field.)
From a review of some of the literature and research on the MTHFR genetic abnormality, mutations of this gene may be implicated with the following:
- elevated homocystiene levels (a potentially toxic amino acid) leading to heart problems
- venous thrombosis
- blood clotting issues
- certain types of severe birth defects (for example, neural tube defects)
- miscarriages
- high blood pressure in pregnancy
- coronary heart disease and stroke
- mental illness, most often connected with depression and possibly schizophrenia
Researchers from all over the world are publishing studies searching for additional connections; a lot more information is on the way
Depression
In reference to my focus on mental health, The Hordaland Homocysteine Study is the one most quoted for their research connecting the MTHFR 677C-T mutation with difficulty metabolizing folate and B12; this leads to issues of elevated homocysteine, anxiety and depression. Another important study is entitled: “The Thermolabile variant of the MTHFR is associated with depression in the British Women’s Heart and Health Study and a meta-analysis.”
Both of these studies suggest that due to the body’s inability to metabolize folate/ B- 12 there is a greater risk of depression. Here is how it appears to work:
- Depressive symptoms may be linked to insufficient neurotransmitters or imbalance of one or more of the three neurotransmitters:
- Serotonin (linked to obsessions and compulsions and memory)
- Nor-epinephrine (linked to alertness, concentration and energy)
- Dopamine (linked to pleasure, reward, motivation and drive)
- When these three neurotransmitters are in sufficient quantity and in balance, anxiety is reduced, impulse control and irritability is minimized, there is a capacity for positive mood and good cognitive function, attention can be maintained, and appetite is in normalized. There is also normalized sexual drive and reduced aggression.
- Your doctor or other health care provider may prescribe antidepressants to treat the imbalance of these neurotransmitters. However, what we have come to see is that a significant portion of the population that does not respond successfully to antidepressants.
- This research may point to the reason for ineffective treatment of depression by antidepressants alone. The theory here is that the brain may not be producing enough neurotransmitters due to insufficient amounts of L-methylfolate in the brain. L-methylfolate is needed to regulate serotonin, nor-epinephrine and dopamine production. Without enough L-methylfolate it may be difficult for the brain to produce enough neurotransmitters for the antidepressant to work fully.
- An abnormality in the MTHFR gene prevents the breakdown of folate/B vitamins; as a result, the neurotransmitter building blocks are not available for health brain function. By taking an activated, or metabolized form of folate/B vitamins the body is then able to produce sufficient neurotransmitters . This alone may improve functioning for some; for others, by combining the activated form of folate/B12 with antidepressants, improved results follow.
- 70 percent of those with a diagnosis of depression may have a specific genetic factor that limits their ability to convert folic acid or folate from food or supplements to L-methylfolate.
- The prescription Deplin is actually L-methylfolate in an active, metabolized form that can cross the blood brain barrier to help the brain regulate these important neurotransmitters associated with mood. This is a prescription item only, and is not available in drug or health food stores off the shelf.
- There are no side effects with this product (as reported by the company that produces Deplin); patient surveys have shown 86 percent symptom improvement.
Test results show that if there is a positive genetic mutation it may be what is called homozygous or heterozygous. Here is a more detailed explanation of the definition of these terms. These definitions are taken from http://medical-dictionary.thefreedictionary.com:
[hō′məzī′gəs]
Etymology: Gk, homos + zygon, yoke
Identical genes controlling a specified inherited trait.
“having two identical alleles at corresponding loci on homologous chromosomes. An individual who is homozygous for a trait has inherited from each parent one allele for that trait. A person who is homozygous for a genetic disease caused by a pair of recessive alleles, such as sickle cell anemia, manifests the disorder. All of his or her offspring will inherit the allele for the disease.”
[het′ərəzī′gəs]
Etymology: Gk, heteros + zygotos, yoked
Two different genes controlling a specified inherited trait.
“having two different alleles at corresponding loci on homologous chromosomes. An individual who is heterozygous for a trait has inherited an allele for that trait from one parent and an alternative allele from the other parent. An individual who is heterozygous for a genetic disease caused by a dominant allele, such as Huntington’s disease, manifests the disorder. A person who is heterozygous for a hereditary disorder produced by a recessive allele, such as sickle cell anemia, is asymptomatic or exhibits reduced symptoms of the disease. The offspring of a heterozygous carrier of a genetic disorder have a 50% chance of inheriting the allele associated with the disorder if the other parent does not carry the allele.”
(While this level of detail is not easily understood, I wanted to insert it here since this is the language that geneticists use in sharing the results of the genetic tests administered.)
What all this complex information means is that it is now possible to effect positive emotional changes by identifying these genetic abnormalities and adding to the treatment regimen an activated (metabolized) B vitamin, thereby aiding in the production of neurotransmitters, which are the basis for health brain function. These are the potential benefits to this protocol:
- motivation
- alertness
- initiative
- concentration
- improved mood
- sociability
This is new information and much more research is needed to understand how the genetic mutations of the MTHFR gene affect us; what is exciting is that the introduction of a natural vitamin may provide the key to improved mental health in over 70% of people with depression.
Does genetics determine our fate? Not necessarily. Some genetic predispositions can be altered by understanding and altering our diet and lifestyle. This is called Epi-Genetics! Above and beyond genetics. Welcome to the new world.
I will keep you posted as I gain more knowledge of this critically important emerging field.
Cynthia
2 Comments »
I have been researching the work of Dietrict Klinghardt, MD, PhD, for months now, seeking to understand his overall approach and underlying assumptions. He has been synthesizing traditional and alternative medicine for over 30 years. He has studied medicine, psychology and spirituality with an over-reaching high level of integrative intelligence . He has studied the effect of heavy metals, environmental pollutants and electromagnetic effects on the human body. He seeks to understand the underlying factors of dis-ease and share his wisdom with us all. His work is comprehensive, broad-reaching and at times, erudite.
Dr. Klinghardt is a neurobiologist, an integrative physician and is a leading proponant of holistic treatment. He studies the nervous system in an interdisciplinary way that involves other disciplines such as psychology, computer science, statistics, physics, philosophy and medicine. He is a fierce advocate for patient self-care; he publishes and teaches his approach in America and Europe to educate us about prevention and natural treatments so that we all have access to the means of cleansing, balancing and healing ourselves. His work is , in many respects, consistent with other naturopathic physicians in that he seeks to assist the human body to function optimally through the use of herbs, homeopathic medicine and lifestyle changes. He has added an energy medicine component for both diagnosis and treatment and is in the forefront in proposing this ancient, and at the same time, newest and most promising approach to healing.
The foundation of his approach is based on his understanding of the five levels of healing. While in India about 30 years ago he went to a lecture given by a Guru (wise man) who talked about an ancient (12,000 years old) Tibetan philosophy based on an understanding of humans as beings comprised of five different levels: the physical, the electromagnetic, the mental, the intuitive body, and the spirit body. All but the physical are invisible to the human eye, although some people can “see”, feel or sense fields of energy relating to the other, usually invisible aspects.
The premise that is most fascinating for our purposes is that in order to be well, all levels of the human being must be healed. This is so because the physical aspect of us is the materiel manifestation of all the other components. The other four layers interpenetrate with the physical and affect the health of the physical being.
Let’s reference each of these layers and briefly touch on how each of these layers relate to illness. Let’s say that a person has been diagnosed with Lyme disease. On a physical level it means that bacterial organisms are multiplying in the body, moving to different parts of the body, generating neuro-toxins which cause symptoms in their own right. It may be that the physical body has been diagnosed with heavy metal toxicity, for example, mercury, and that the toxins need to be cleared so that the body may more effectively fight it’s battle against the bacterial invaders. This is the world of orthomolecular and allopathic medicine. On this level antibiotics may be prescribed to kill off the unwanted organisms, detoxifying herbs given for clearing out the neuro-toxins and by-products of the die-off.
On the second level, the electromagnetic level, it may be seen that the patient has developed an inflammatory response (physical level) that produces inflamed, painful energy in response to the direct effect of the bacteria, or the by-products of their living and dying. This energy may be present in the physical mass of muscles, joints,or organs. Since pain causes us to contract, resist or avoid, that energy may become stuck or constricted. Within this model, healing energy work, such as Reiki, Hands on Healing, acupuncture, reflexology, or (in Dietrict Klinghart’s lexicon) Autonomic Response testing may be used. Through the movement and clearing out of painful, inflamed energy the void is then filled with the natural life force within all human beings; it then has a chance to flow and heal. Note: according to this model, the layers below (in this case the physical) are affected positively.
On the third level, the mental body, unresolved emotional conflict creates a disturbance in (what is known in neuroscience as) the bio-photon field which surrounds the body, and is generated by the DNA.
Neuro-science tells us that short term memory is tracked in brain circuitry (first level); according to this way of understanding the human, long term and extrasensory perceptions reside in the energy field that surrounds the body- the physical brain is seen as a “tuner” for memory storage.
Fritz-Albert Popp, a German physicist pioneered research about the vibrational nature of our cells, and is reported to have confirmed the existence of biophotons which emit tiny quantities of light. We are beginning to understand how these invisible entities communicate complex information and orchestrate metabolic function. For details about this go to mercola.com to see an interview of Klinghardt on the subject – fascinating!)
If this Lyme disease patient were to enter into psychotherapy there may be found traumatic, unresolved issues in their own life history, or in the family history that may have been passed on. This unresolved history is held in the field of energy that surrounds the physical body. By facing and resolving this (conscious, unconscious or sub-conscious) pain, that then allows a flow and healing of the energy body that would otherwise weigh down or inhibit full healing.
The forth level of healing is identified as the Intuitive body. It is realm of the shaman, the religious, the spiritual, and your metaphysical experiences. Dr. Klinghardt postulates that on this level unresolved conflict and trauma from a person’s past and from their history can generate physical illness. Unless these traumas are faced and resolved, they may act out these unresolved issues in spite of a medical approach dealing only with the physical body.
So for our purposes, with this same Lyme disease patient, if this person, for example, had parents or grandparents who were sexually or physically abused, the unresolved trauma may be carried on the the person’s memory/field of energy; unless faced, mourned and the associated feelings of anger, rage and despair are released, the effects of the trauma are played out in the present. Klinghardt developed something he calls Family Constellation work to delve into the family history and therapeutically identify and resolve the trauma.
Our Lyme patient may receive the best treatment for the physical components of Lyme disease, but, according to this model, the patient will be vulnerable to continued illness unless this “contaminating” emotional disability is healed through psychotherapy, family therapy or other uncovering and healing teahniques.
The fifth level of healing, the individual’s connection to the divine, is deeply personal, and is the most important and largest part of the human being. This is the level of self-healing and relates to the “highest self”.
Klinghardt’s premise is that illness can originate on any of the four lower levels and unless the source of the illness is healed disease will be resistant to healing, or it may transform into another form of disease. Illness that is treated symptomatically but that does not treat the actual cause of the illness is short-sited and will likely be unsuccessful.
This concludes my summary of Dr. Klinghardt’s work. I hope you have found it as stimulating and as interesting as I have. Please let me know what your thoughts are, and send along any questions you may have!
Cynthia
11 Comments »
BIOFILM: A NEW HIDEOUT FOR BORRELLIA BURGDORFERI
It is as though Dr.Eva Sapi is on a Safari in the deepest jungle in Africa. She is mapping out a totally unknown area of the world filled with dangerous animals, new forms of life never seen by man (or woman) and she is armed only with her microscope. She is in this reality Eva Sapi, Ph.D., assistant professor of cellular and molecular biology at the University of New Haven, Connecticut. Her brand new article in the Lyme Times summarizes her research on an entity called biofilm. A rather dry word, but an amazing concept. For those of us lay persons interested in Lyme disease and co-infections and why it appears that some people have chronic infection the concept is revolutionary in its possibilities.
Here is how it works: the research shows that when enough microbes gather they begin to adhere to each other or to living or inert surfaces. These organisms then communicate to each other and start a change in “gene expression” that allows the cells to produce something called “exopolysaccharide” which becomes a “protective matrix“.
Like a moat which surrounds the castle it provides protection from attacking forces – like phagocytes or antibacterial agents! Not only that, German scientists using marine bacteria identified that this biofilm actually is capable of releasing a paralyzing agent. “It appears that biofilm is not just a defensive fortress, it can also fight back.”
Dr. Sapi in conjunction with Dr. Alan MacDonald has recently worked “in vitro” to study biofilm formation of Borrelia burgdorferi. In her words: “In summary, if we can demonstrate that biofilm structure of Borrelia burgdorferi renders them resistant to antibiotics, it could provide a logical explanation as to why extensive antibiotic treatment for patients with a tick-bite history could fail. The end result from our study could provide novel therapeutic approaches for Lyme literate physicians to explore for chronically ill patients”
Please go to lymetimes.org for the above-reviewed article in its entirety and join to receive the most up-to-date research and support.
Cynthia
2 Comments »
Update: More good news
CT Doctor Protection Bill Passes House
April 30, 2009- Connecticut Lyme groups and the national Lyme Disease
Association, Inc. are pleased to announce that H.B. 6200, with a floor
amendment by Representative Betsy Ritter et al., passed through the
Connecticut House of Representatives.
The House vote was unanimously in support of the bill by a final vote of 137
to 0.
The discussion on the floor this morning clearly delineated the protective
intent of the bill. The bill will now proceed to the Senate for
consideration.
H.B. 6200 contains language that will protect CT licensed Lyme treating
physicians from prosecution by the State of Connecticut Medical Examining
Board solely on the basis of a clinical diagnosis and /or for treatment of
long-term Lyme disease.
The bill provides the definition for Lyme disease which includes , “the
presence in a patient of signs and symptoms compatible with acute infection
with Borrelia burgdorferi; or with late stage or persistent or chronic
infection with Borrelia burgdorferi, or with complications related to such
an infection.”
It also defines clinical diagnosis as determined by a physician “.that is
based on knowledge obtained through the medical history and physical
examination alone, or in conjunction with the testing that provides
supportive data for such clinical diagnosis.” In addition, it provides for
updating the definition if other strains are found to cause Lyme disease.
The final bill was the result of months of negotiations between Legislative
leaders, the Connecticut Department of Public Health and the undersigned
groups representing patients.
We would like to thank Representatives Jason Bartlett, Kim Fawcett, Chris
Lyddy , Peggy Reeves and all of the legislators who supported this bill.
We would also like to thank the Legislative leadership for taking time from
their busy schedules to meet with us over the past several weeks. We
particularly thank the joint Public Health Committee Chairs, Representative
Betsy Ritter and Senator Jonathan Harris and the Public Health Committee for
understanding this complex issue and its importance to patients in CT.
We would like to extend our appreciation to the patients, families and
members of the Lyme community who wrote letters, made phone calls and
testified in support of H.B. 6200.
We have confidence that the Connecticut Senate will fulfill its commitment
to CT residents and pass this important piece of legislation intact.
Please note this bill has moved from the Public Health Committee; it still
needs to be passed by the House; Senate and Rell; but is big step!
=========================
http://www.newstimes.com/ci_12005818
Controversial Lyme disease bill passed by legislative Public Health
Committee
By Brian Lockhart
Staff Writer
Updated: 03/26/2009 11:03:49 PM EDT
HARTFORD — The Legislature’s Public Health Committee unanimously passed a
bill about tick-borne Lyme disease Thursday that could rock the health care
industry if it becomes law.
“This is a huge message,” state Rep. Kim Fawcett, D-Fairfield, the bill’s
sponsor, said after the panel approved the proposal without debate.
The proposal would validate the treatment of chronic Lyme disease in
Connecticut. It clarifies to physicians, despite an opinion from the
Infectious Disease Society of America that chronic Lyme disease does not
exist, that they do have the right to diagnose and prescribe long-term
antibiotics for the illness without fear of reprisal by the state.
“The thing that’s important to us is we send a clear message, ‘It’s OK to go
outside the Infectious Disease Society of America guidelines,’” said
Fawcett, who is not a member of the health panel.
Discovered in the mid-1970s in Connecticut, Lyme disease is transmitted to
humans by the bite of infected blacklegged ticks.
Symptoms include fever, headache, fatigue and a rash. If untreated,
infection can spread to joints, the heart and the nervous system.
The commonly accepted treatment is up to 28 days of antibiotics. But some
patients are convinced they suffer from chronic Lyme disease and need longer
courses of antibiotic treatment.
But the Infectious Diseases Society, which in 2006 developed updated
treatment guidelines for doctors, dismisses chronic Lyme disease as
Advertisement
a myth.
“There are no convincing published scientific data that support the
existence of chronic Lyme disease,” Anne Gershon, president of the
Virginia-based society, wrote lawmakers in February.
She wrote that the concept of chronic Lyme disease has been promoted by “a
small group of physicians” but the dangers of long-term antibiotic therapy
are well-documented and should not be encouraged by legislation like the
bill passed by the committee Thursday.
State Rep. Jason Bartlett, D-Bethel, another bill sponsor who sits on the
Public Health Committee, told colleagues Thursday the legislation would
address the dueling “standards for practice” that have arisen over chronic
Lyme disease.
“Because of these two disagreements the (Connecticut) Department of Public
Health, we feel, has been biased towards the 28 days of antibiotics,”
Bartlett said.
He said the result is a “chill effect” on physicians who might otherwise be
willing to diagnose and treat chronic Lyme disease.
Following a public hearing on the bill in early February, William Gerrish, a
spokesman for the health department, said there is no state policy against
long-term antibiotic treatment of Lyme disease.
Gerrish said state health officials are concerned the bill as written would
strip the department of its ability to review complaints and violations,
particularly in cases where the care being provided to a patient deviates
from current, evidence-based practice.
No doctors offered testimony in February that they felt persecuted by the
state health department for treating chronic Lyme disease.
But at the time, Matthew Katz, vice president of the Connecticut State
Medical Society, confirmed there are concerns among physicians over the
state’s recent actions against Dr. Charles Ray Jones, a New Haven
pediatrician renowned for treating chronic Lyme disease.
In December 2007, the state Medical Examining Board, responding to an
investigation by the Department of Public Health, fined Jones $10,000 and
put him on probation for two years for diagnosing children with Lyme disease
and treating them with antibiotics before examining them.
Jones is appealing the decision.
Katz said news coverage focused on the doctor’s reputation as a last resort
for those complaining of chronic Lyme disease.
“What appeared in the paper and on the news — Lyme disease mistreatment –
it raised a lot of concerns,” Katz said at the time.
Fawcett’s bill states that as of July 1, 2009, the Medical Examining Board
may not discipline a licensed physician “solely for” prescribing,
administering and dispensing long-term antibiotic therapy to a patient
clinically diagnosed with Lyme disease as documented in their medical
records.
The State Medical Society backs the concept of the bill, but is not taking a
position on the existence of chronic Lyme disease.
Gerrish said the Department of Public Health is still hoping to work with
the health committee to “preserve our ability to conduct a thorough
investigation to protect the public.”
“That bill is perfect in our eyes,” Fawcett said.
But Health Committee co-chairwoman state Rep. Betsy Ritter, D-Quaker Hill,
told her colleagues before Thursday’s vote the legislation may change before
going to the full General Assembly.
“There will be “at least a bit more work going on with this bill before
we’re finished,” Ritter said.
On 3/27/09 6:06 AM, “Maggie Shaw” <Lancaster60@aol.com> wrote:
Click here: Controversial Lyme disease bill passed by legislative Public
Health Committee – NewsTimes.com <http://www.newstimes.com/ci_12005818>
_____
No Comments »
The Healing Power of our Past- I wrote a portion of a chapter in this book called “The Process Unveiled” revealing the use of hypnotherapy in uncovering the past; the chapter discusses how a specifically designed hypnosis protocol helps the client re-experience past trauma, then releases that pain in a method called “Guided Light Therapy”: (developed by Dr. Norton Berkowitz).
Excerpts follow:
“I decided to enter into training with Norton, both as an adventure and as an exploration into these fantastic possibilities of understanding ourselves more deeply, and to determine the usefulness of these approaches in healing, especially for psychoanalytical use. My learning goal was both personal and professional. Although the techniques of Life Memory Recall and Guided Light Therapy sounded easily reproducible, I knew they were not and I knew I needed guidance to learn them. These techniques developed out of years of experience and as a culmination of information Norton retrieved from working with Hollie. … Since that time I have hypnotized many of my patients. I have seen them speak in foreign languages, some of the languages reputedly long lost in history. I have heard endless adventures, sagas, traumas relived. I have seen incredible remissions of long-standing symptoms in my patients that the traditional methods of psychotherapy were unable to affect. I have seen terrible pain and suffering released, allowing the patient to go on free of his or her burdens.”
“The Healing Power of our Past” by Dr. Norton Berkowitz and Dr. Hollie Martin. Published by iUniverse, Inc, New York Lincoln Shanghai, Copyright 2005
Want to buy it? Amazon link: The Healing Power of our Past
No Comments »
|